Search
for
Sort by
Research 121–150 of 777
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman
- The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature
- Efficacy of tofacitinib in pediatric alopecia universalis
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Real-World Experience of Tofacitinib and Baricitinib Use in Alopecia Areata in Greek Population: A Retrospective Analysis With Focus on Safety
- Successful treatment with upadacitinib in concurrent atopic dermatitis, Crohn’s disease, alopecia areata, and eosinophilic gastropathy in a pediatric patient
- Upadacitinib Efficacy for the Treatment of Concomitant Psoriasis and Alopecia Areata
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- The role of janus kinases in the treatment of autoimmune skin diseases
- Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- A review of Janus kinase inhibitor use in scarring alopecia
- Progressive alopecia areata during TNF-α inhibition with intralesional corticosteroid failure and subsequent improvement following JAK1 inhibition
- JAK1 gain-of-function variant causes alopecia areata, atopic dermatitis, and autoimmune thyroid disease
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- The development of oral hairy leukoplakia during JAK inhibitor baricitinib therapy
- A Bibliometric Analysis of Alopecia Areata Literature over the Past 50 Years.
- Pharmacological Treatment of Alopecia
- Alopecia Areata: Current Review
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma – Multifaceted Control
- Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata
- Complete Regrowth of Beard Hair with Ruxolitinib in an Alopecia Universalis Patient
- Comparative analysis of therapeutic outcomes in pediatric versus adult ophiasis-pattern alopecia areata: A review of treatment modalities and disease course
- Revolutionary Approaches to Hair Regrowth: Follicle Neogenesis, Wnt/ß-Catenin Signaling, and Emerging Therapies